China: A recent study published in the Journal of the American Heart Association has unveiled a compelling association ...

Premier, Inc. announced the nation’s 50 Top Cardiovascular Hospitals® with the full list of recognized hospitals published in ...

Background Studies have shown an increased risk of cardiac disease following COVID-19, but how it compares to pneumonia of ...

The following is a summary of “Impact of impaired renal function on kinetics of high-sensitive cardiac troponin following ...

The virus was linked with the rapid growth of plaque in the coronary arteries which increases the chances of major ...

Background Primary prevention strategies for cardiovascular disease (CVD) conventionally rely on 10-year risk estimates of ...

The Tamil Nadu Health Department has issued an alert to district health officers as cases of scrub typhus continue to rise ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The statistics from the CDC are stark: in the United States, someone has a heart attack every 40 seconds. Every year, about ...